Home › Cholesterol › Virginia › Richmond
Cholesterol clinical trials in Richmond, VA
4 studies for Cholesterol are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Chippenham Hospital, Richmond
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
RecruitingPhase 3
- Research Site, Richmond
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
RecruitingPhase 2
- Dominion Medical Associates, Richmond
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
RecruitingPhase 3
- Virginia Commonwealth University, Richmond
About Cholesterol
Your body needs some cholesterol, but too much can raise your risk of heart disease. Know the types (HDL and LDL), and how to lower high cholesterol.
More about Cholesterol on MedlinePlus
Cholesterol trials in other cities
- Washington, DC7 studies
- Hialeah, FL6 studies
- Jacksonville, FL5 studies
- Houston, TX4 studies
- Deltona, FL4 studies
- St. Louis, MO3 studies
- Salt Lake City, UT3 studies
- San Francisco, CA3 studies
- Anderson, SC3 studies
- Chicago, IL3 studies
- Winston-Salem, NC3 studies
- Wichita, KS3 studies
Other studies in Richmond
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Prostate Cancer19 studies
- Heart Failure17 studies
- Lung Cancer15 studies
- Cardiovascular Disease13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Colorectal Cancer13 studies
- Cancer (all types)12 studies
- Metastatic Cancer12 studies
- Diffuse Large B-Cell Lymphoma11 studies
- Steatotic Liver Disease11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.